Among the world's top 10 most-cited Immunology journals
Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology.
Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS).
Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. Field Chief Editor Luigi Daniele Notarangelo is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis. Further, the availability of a growing number of biological drugs, coupled with fine characterization of the molecular mechanisms of disease, has now made precision medicine a desirable approach for many immunological disorders. Frontiers in Immunology portrays how advances of scientific knowledge and technology may translate into novel approaches to diagnosis and treat immune disorders, both in animal and cellular models and in humans.
All manuscripts submitted to Frontiers in Immunology that report on studies conducted in human subjects must conform with current regulation and the Declaration of Helsinki, and must receive approval from the Institutional Review Board and patient informed consent. Animal welfare and Ethics Committee approval is required for studies involving animals.
Frontiers in Immunology is organized into Specialty Sections that cover different areas of research in Immunology. Authors should refer to the author guidelines for details on article types and the submission process.
Frontiers in Immunology is a member of the Committee on Publication Ethics.
Short Name: Front. Immunol.
Electronic ISSN: 1664-3224
Indexed in: PubMed, PubMed Central, Scopus, Web of Science, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), EMBASE, Semantic Scholar, Ulrich's Periodicals Directory, CLOCKSS, EBSCO, OpenAIRE, Zetoc
PMCID: all published articles receive a PMCID
Frontiers in Immunology is composed of the following Specialty Sections:
The specialty sections of Frontiers in Immunology welcome submission of the following article types: Brief Research Report, Case Report, Classification, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Review, Study Protocol, Systematic Review, Technology and Code, Clinical Study Protocol, Data Report, Protocols, Specialty Grand Challenge, Addendum and Erratum.
When submitting a manuscript to Frontiers in Immunology, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.
Articles published in the specialty sections above will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in the Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Immunology.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com